AR035273A1 - Pramipexol para el tratamiento del adhd - Google Patents
Pramipexol para el tratamiento del adhdInfo
- Publication number
- AR035273A1 AR035273A1 ARP020102946A ARP020102946A AR035273A1 AR 035273 A1 AR035273 A1 AR 035273A1 AR P020102946 A ARP020102946 A AR P020102946A AR P020102946 A ARP020102946 A AR P020102946A AR 035273 A1 AR035273 A1 AR 035273A1
- Authority
- AR
- Argentina
- Prior art keywords
- adhd
- treatment
- pramipexol
- tetrahyde
- pilamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10137633A DE10137633A1 (de) | 2001-08-03 | 2001-08-03 | Pramipexol zur Behandlung von ADHD |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035273A1 true AR035273A1 (es) | 2004-05-05 |
Family
ID=7693957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102946A AR035273A1 (es) | 2001-08-03 | 2002-08-02 | Pramipexol para el tratamiento del adhd |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1416930A1 (de) |
| JP (1) | JP2005500368A (de) |
| AR (1) | AR035273A1 (de) |
| CA (1) | CA2453485A1 (de) |
| DE (1) | DE10137633A1 (de) |
| MX (1) | MXPA04001001A (de) |
| UY (1) | UY27408A1 (de) |
| WO (1) | WO2003013520A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200906997A1 (tr) | 2009-09-11 | 2011-03-21 | Sanovel �La� San. Ve T�C. A. �. | Pramipeksol farmasötik bileşimleri. |
| TR200907554A1 (tr) * | 2009-10-06 | 2011-04-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Oral yolla dağılan pramıpexole bileşimleri. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5621133A (en) * | 1989-05-31 | 1997-04-15 | Deninno; Michael P. | Dopamine agonists |
| AU2001261694A1 (en) * | 2000-05-19 | 2001-12-03 | Wayne State University | Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior |
| US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
-
2001
- 2001-08-03 DE DE10137633A patent/DE10137633A1/de not_active Withdrawn
-
2002
- 2002-07-31 MX MXPA04001001A patent/MXPA04001001A/es not_active Application Discontinuation
- 2002-07-31 JP JP2003518529A patent/JP2005500368A/ja active Pending
- 2002-07-31 WO PCT/EP2002/008500 patent/WO2003013520A1/de not_active Ceased
- 2002-07-31 EP EP02762417A patent/EP1416930A1/de not_active Withdrawn
- 2002-07-31 CA CA002453485A patent/CA2453485A1/en not_active Abandoned
- 2002-08-02 UY UY27408A patent/UY27408A1/es not_active Application Discontinuation
- 2002-08-02 AR ARP020102946A patent/AR035273A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04001001A (es) | 2004-04-20 |
| DE10137633A1 (de) | 2003-02-20 |
| EP1416930A1 (de) | 2004-05-12 |
| UY27408A1 (es) | 2003-02-28 |
| JP2005500368A (ja) | 2005-01-06 |
| CA2453485A1 (en) | 2003-02-20 |
| WO2003013520A1 (de) | 2003-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28034A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparacion asi como su empleo como medicamentos | |
| UY28040A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos. | |
| ECSP088593A (es) | 5-(arilsulfonil)-pirazolopiperidinas | |
| DE602005023185D1 (de) | Prodrugs mit neuen biospaltbaren verbindern | |
| UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
| SV2003001107A (es) | Imidazotriazinas ref.lea 35368 | |
| SV2002000169A (es) | Nuevos derivados del acido aminodicarboxilico con propiedades farmaceuticas ref. lea 33878-sv | |
| ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
| UY29437A1 (es) | Nuevos antagonistas de cgrp | |
| AR002043A1 (es) | Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria. | |
| UA83691C2 (ru) | Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона | |
| UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| DK1162982T3 (da) | Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| SE0400043D0 (sv) | New compounds | |
| UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
| ECSP045156A (es) | Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6 | |
| CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| UY27451A1 (es) | 2,5-diamidoindoles sustituidos y su utilización | |
| AR035273A1 (es) | Pramipexol para el tratamiento del adhd | |
| AR055011A1 (es) | Compuesto de tetrahidroquinolina, proceso de preparacion del compuesto y su uso para la preparacion de un farmaco | |
| BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
| AR028970A1 (es) | USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE | |
| AR026242A1 (es) | Empleo de 2-amino-3,4-dihidro-quinazolinas para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas por estadosisquemicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |